| Prev Close | 45.91 |
| Open | 46.11 |
| Day Low/High | 45.34 / 47.25 |
| 52 Wk Low/High | 33.80 / 64.94 |
| Volume | 124.56K |
Eagle Pharmaceuticals, Inc. (EGRX)
46.48
0.57
1.24
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 13.50B |
| Market Cap | 627.08M |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
3 Busted IPOs That Could Be Good Investments
This unloved part of the market has frequently produced some of the biggest gainers within my personal portfolio over the years.
Rules of Biotech Investing Change, and So Must Biotech Investors
One big change over the last few years has been the struggle of small concerns to penetrate mass markets even with approved and superior drugs.
Three Biotech Names to Consider
A look at three names to consider in the biotech and biopharma space.
3 Biotech Values in a Fully Valued Market
Eagle Pharmaceuticals, Aratana Therapeutics and Progenics Pharmaceuticals show promise.
3 Biotech Values in a Fully Valued Market
Eagle Pharmaceuticals, Aratana Therapeutics and Progenics Pharmaceuticals show promise ahead.
Oversold Small-Cap Biotech Names
I am working incrementally into some small stocks with great long-term value.
Three Health-Care Growth Plays
Eagle Pharmaceuticals, Invitae and Celgene should do well this year and are attractively priced.
3 Small-Caps Bucking the Downtrend
News announcements from these companies are supportive of continued strength.
3 Small-Caps Bucking the Downtrend
News announcements from these companies is supportive of continued strength.
How to Play It When the FDA Slams Your Stock
Here are three recent examples of how the patient can profit.
Shark Bites: Join the Momentum Parade
The benefits of following the big movers.
A Mid-Year Look at 4 Best Ideas Picks
I still like and own these small-caps.
Biotech Gets a Lifeline
Solid earnings and the start of some M&A activity may be just what this sector needs to rise.
2 Small-Cap Biotechs With Big Ambitions
Inovio Pharmaceuticals and Eagle Pharmaceuticals both boast solid pipelines and sound balance sheets.
Stocks Give Up Some Gains as Oil Tanks
The market has given up a good portion of its early gains in last hour or so, while oil -- which rallied above $41 a barrel earlier today to reach a new 2016 high -- is back near $39.50. JPMorgan Chase has turned bearish on the U.S. dollar and bulli...
Markets Open Higher, But Eagle Pharma Tanks
Markets have opened slightly higher this morning, with some stocks worth calling out. Las Vegas Sands (LVS) is continuing its recent winning streak, as Macquarie boosted outlook for companies that operate casinos in the Chinese gambling hub of Macau...
2 'Rules of the Road' for Biotech Investing
Follow these maxims and you should do well in this volatile sector.
BioDelivery Is About to Start Delivering
The company cleared an important hurdle last month.
That Was the Week That Was
Let's review.
Eagle Pharmaceuticals Ready to Soar Again
After flying high most of the year, the biopharma company is back on my radar.
Biotech: Partnerships Spell Success
Bet on small-caps with big-name collaborators.
Ride 'Shotgun' to Avoid Investing Mistakes
Try small stakes in several sector names to improve your odds. Also, don't trade after hours.
Bears: The Gang That Couldn't Shoot Straight
They have the ammunition but they keep misfiring in the market.
Bit of a Bounce Brings Sigh of Relief
Uncertainty on Greece prevails, but it could have been worse.
Oblivious Market Keeps Chugging Along
But Greece still holds the potential for a surprise.
It's Yellow Light Time in the Market
Caution should trump fear of missing out on further gains.
Playing Biotechs with the House's Money
Here's how to lock in gains on risky small-cap biotechnology stocks.
